Communication mission is mainly to facilitate the conversation between ECUSA and the society, both in Spain and in the United States. Also promote the organization by making known the activities and events done and serve as a platform to inform about the work of Spanish scientists in the US.
We want to magnify the visibility of science in the society and we have a variety of programs that are used to spread information related to science to everybody. In conclusion, we are building a Spanish speaking scientist network both in the United States and Spain, facilitating the interactions between members and the exchange of information.
Fernando de Miguel Sánchez de Puerta
Fernando is a molecular biologist with vast experience in cancer research. He studied a degree in Biochemistry at the University of Navarra (UNAV) prior to an MSc. in Molecular and Cellular Biology at Universidad Autónoma de Madrid (UAM). He returned to Pamplona, where he obtained her PhD at the Center for Applied Medicina (CIMA) at the University of Navarra He moved to the USA in 2016 to study epigenetic mechanisms of resistance to targeted therapies e immunotherapies in lung cancer as a postdoctoral researchers at the Yale Cancer Center, in Yale University, New Haven, CT. Currently, he works as a Senior Scientist at the company Tyra Biosciences in San Diego, CA, where he researches new targeted therapies for cancer and other diseases.
Carmen is a postdoctoral researcher at the Ragon Institute of MGH, MIT and Harvard (Cambridge, MA). After finishing a Bachelor’s degree in Biology from the University of Alcalá, she completed a research master’s degree at the University College London (United Kingdom) and later obtained a PhD in Biomedicine from the University of Barcelona. After a first two-and-a-half-year postdoc at Fudan University in Shanghai, she moved to Boston, where she spent a year working in a laboratory at Harvard/Brigham and Women’s Hospital. In 2022, she joined the Ragon Institute, where she is currently working on understanding how cells of the immune system are able to survive and function within unfavorable environments. In ECUSA, Carmen is co-Chair of Communication, she actively collaborates with the Women in Science committee (MECUSA) and she is also on the board of ECUSA Boston.
Antonio Cembellin Prieto
Noemí Arias Rueda
Midwest Communication Director
Noemí is a Postdoctoral Researcher in the Department of Biochemistry and Molecular Biology at Saint Louis University, Saint Louis, Missouri. Noemí focuses on understanding the mechanisms of how fat accumulates and distributes in the body to find therapeutic targets to treat metabolic disorders such as obesity, fatty liver disease, or cardiovascular disease. Noemí graduated in Pharmacy at the University of the Basque Country. She also completed a Master in Nutrition and Health followed by a Ph.D. in the Department of Pharmacy and Food Science at the same University. During her pre-doctoral stage, Noemí spent 6-months at the University of Stockholm, Sweden, to complete her international Ph.D. studies. Shortly after defending her thesis, Noemí moved to the US with a postdoctoral fellowship from the Basque Government. Noemí collaborates in the E-visibility program and ECUSA communication, increasing the dissemination of scientific projects made by Spanish scientists.
Juan Enríquez Traba
Juan is a third-year PhD student at the National Institute of Mental Health (Bethesda, MD). During his studies in Biochemistry at the Autonomous University of Madrid, Juan began doing research at the Cajal Institute on Parkinson’s and drug addiction. After completing his degree, Juan moved to Scotland to pursue a Master’s in Biotechnology at the University of Edinburgh. To pursue his current doctorate, Juan decided to build a collaboration with the NIH through its Graduate Partnership Program, of which he is currently a beneficiary. Juan studies the role of the D3 receptor in the context of neuropsychiatric diseases. Juan has been a member of the ECUSA Board of the DC chapter since 2019 and is also a member of the communication commission.
Emma Muíños López
Emma did her doctoral thesis on cartilage regeneration with amniotic membrane stem cells at the Institute for Biomedical Research of A Coruña (INIBIC). She continued with her first postdoc at the Clínica Universitaria de Navarra working on in vivo screening of bioprinted biomaterials. She moved to New York in 2018 for her second postdoc at NYU Langone Health on Inflammaging. Her research is focused on understanding how the immune system affects bone regeneration during aging, with the aim of improving fracture repair in older patients.
Leire Abalde Atristain
Leire is a neuroscientist from Donostia-San Sebastian who completed her undergraduate studies in Biotechnology at the Autonomous University of Barcelona and a master’s in Biomedical Research at the Pompeu Fabra University, also in Barcelona. Sponsored by a predoctoral fellowship from the La Caixa Foundation, Leire moved to the US in 2013 to obtain her doctorate from the Johns Hopkins University, where she was recognized with a Young Investigator Award for her thesis work. She is currently a postdoctoral researcher with Dr. Marc Freeman at Oregon Health & Science University, where she studies the role of glial cells in the degeneration of neurons in the central nervous system. Leire joined the ECUSA’s e-Visibility program in 2020 because of her passion for science communication, her conviction that without Science there is no future, and her STEMinist ideals. Since 2021 she also leads MECUSA in its mission to empower women scientists, improve their visibility, and advocate for gender equity in science.
Virginia Del Solar
Virginia, born in Asturias and holder of a degree in Chemistry from the Universidad de Oviedo, earned her doctorate in Chemistry from Universidad Autónoma de Madrid in 2012, moving to Buffalo (New York, USA) few weeks later. She was Associate Postdoctoral Researcher at the State University of New York at Buffalo where she studied the involvement of lipids in different biological processes and the effect of synthetic glycosides on the inflammatory response. Subsequently, she worked as a Research Associate at Brooklyn College and Memorial Sloan Kettering Cancer Center in New York City where her research focused on the distribution of gold antitumor complexes as antibody drug-conjugates (ADCs) or peptide nanoparticles. She is currently working on biomarker discovery as a scientist at Cell and Gene Therapy Catapult, a UK-based company that collaborates with universities and other companies in order to achieve safer, more effective, scalable and affordable cell and gene therapies.
Comunicación Director of California
Alba is a PhD graduated from Barcelona. She pursued her postdoctoral studied in the University of New York (NYU) and in the University of California in San Francisco (UCSF) where she studied mechanisms of immune suppression in cancer. She is now leading a project at the biotech startup Senti Biosciences developing novel cell therapies for cancer.
David Meseguer García
David is a Pharmacist from the University of Valencia (UV) and he has been interested in science from the very beginning, being part of research groups such as the Pharmacogenetics platform (IIS La Fe) where he learned about the implementation of this discipline in pediatric oncology, or Doreal laboratory where he studied the relationship between Mu-opioid receptor and Neuroimmunity. After finishing his studies, he moved to New Haven, Connecticut to start his scientific career as a Research Assistant in the Cellular and Molecular Physiology Department located at Yale School of Medicine. There, he advances in the understanding of how neuronal, immune and vascular networks coordinately control energy homeostasis, applying this knowledge to the study of illnesses like obesity. In the following years, he is planning to enroll a PhD program.